Tilray Brands (TLRY) TD Cowen 9th Annual Future of the Consumer Conference summary
Event summary combining transcript, slides, and related documents.
TD Cowen 9th Annual Future of the Consumer Conference summary
3 Feb, 2026Business diversification and strategy
Diversified from cannabis into beverages, wellness, and distribution due to regulatory limits and market size in Canada.
Acquired multiple companies in Canada, the US, and Europe, including beer, spirits, and wellness brands.
US operations focus on beer, spirits, and hemp-derived drinks, with no cannabis sales due to federal restrictions.
European business includes medical cannabis and pharmaceutical distribution in 20 countries.
Sales split roughly 30% cannabis, 30% beverage, 30% distribution, and 10% wellness.
Operational initiatives and marketing
Regionalizing and focusing on select states for craft beer brands, emphasizing innovation and new product launches.
Closed two breweries to improve efficiency and reduce costs, aiming for higher capacity utilization.
Leveraging 700-900 distributors, with plans to consolidate and strengthen distributor relationships.
Investing in social media, event marketing, and sports sponsorships to build brand equity.
Non-alcoholic and light beer products launched, with Runner's High now in 4,500 locations.
Regulatory environment and market challenges
Canadian growth limited by high excise taxes and illicit market competition; lobbying for tax reduction and broader retail access.
US cannabis drinks limited to 13 states due to state-level regulations; lobbying for expansion but cautious on predictions.
Beer distributors support Delta-9 drinks for growth, while large brewers wait for regulatory clarity.
European market restricted to flower sales; pre-rolls and other formats not permitted.
Timing and permit delays in Europe affected revenue guidance.
Latest events from Tilray Brands
- Acquisition creates a $500M global craft beverage platform and accelerates international growth.TLRY
M&A announcement2 Mar 2026 - Record revenue and EBITDA growth, margin gains, and strong outlook for continued expansion.TLRY
Q4 20242 Feb 2026 - Q1 revenue hit $200M (+13% YoY), led by beverage growth and margin gains, with net loss improvement.TLRY
Q1 202519 Jan 2026 - Q2 revenue hit $211M (+9% YoY), with margin gains and Project 420 synergies advancing.TLRY
Q2 202510 Jan 2026 - Record Q2 revenue, improved net loss, and net cash position; 2026 guidance reaffirmed.TLRY
Q2 20269 Jan 2026 - Diversified global platform drives growth in cannabis, beverage, and wellness with strong financials.TLRY
Investor Presentation8 Jan 2026 - Record Q1 revenue and return to profitability driven by cannabis and distribution growth.TLRY
Q1 202622 Dec 2025 - Proxy covers director election, auditor ratification, pay, and board declassification proposals.TLRY
Proxy Filing2 Dec 2025 - Shareholders to vote on board declassification, share increase, and executive compensation reforms.TLRY
Proxy Filing2 Dec 2025